Historique
Périodique
Residential substance user treatment programs as venues for HCV pharmacological treatment: client and staff perspectives
(Programmes de traitement résidentiel pour usagers de drogue comme lieux de traitement pharmacologique de l'hépatite C : perspectives pour les usagers et les équipes)
Auteur(s) :
STRAUSS, S. M. ;
ASTONE, J. M. ;
MUNOZ-PLAZA, C. E. ;
HAGAN, H. ;
DES JARLAIS, D. C.
Année
2005
Page(s) :
1811-1829
Langue(s) :
Anglais
Refs biblio. :
45
Domaine :
Drogues illicites / Illicit drugs
Discipline :
MAL (Maladies infectieuses / Infectious diseases)
Note générale :
Substance Use and Misuse, 2005, 40, (12), 1811-1829
Note de contenu :
tabl.
Résumé :
ENGLISH :
Hepatitis C virus (HCV) infection is highly prevalent among drug users. While there are antiviral medications available to combat the virus, the medication regimen is quite arduous, presenting special issues for drug users. We examined the challenges and benefits of using residential substance user treatment programs as venues for clients to undergo HCV medication regimens. Analyses of qualitative data collected from clients and staff in 2003 at four residential substance user treatment programs in the U. S. indicate that challenges primarily include issues involving the medications' side effects, and both financial and communication concerns. Benefits especially involve clients' feelings that they are being proactive in addressing health issues in an environment that provides much-needed support. Findings illuminate the complex issues involved for both clients and the programs, and some steps that programs can take to better support HCV infected clients regarding HCV medication concerns. (Editor's abstract.)
Affiliation :
National Development and Research Institutes, Inc., 71 West 23rd Street, 8th floor, New-York 10010. E-mail : straussndri.org
Etats-Unis. United States.
Etats-Unis. United States.